Biolase Stock Shares Owned By Institutions
| BIOLDelisted Stock | USD 0.05 0.02 27.46% |
BIOLASE fundamentals help investors to digest information that contributes to BIOLASE's financial success or failures. It also enables traders to predict the movement of BIOLASE Stock. The fundamental analysis module provides a way to measure BIOLASE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BIOLASE stock.
BIOLASE |
BIOLASE Company Shares Owned By Institutions Analysis
BIOLASE's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current BIOLASE Shares Owned By Institutions | 8.97 % |
Most of BIOLASE's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BIOLASE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
CompetitionBased on the latest financial disclosure, 8.97% of BIOLASE are shares owned by institutions. This is 79.91% lower than that of the Health Care Equipment & Supplies sector and 83.81% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 77.12% higher than that of the company.
BIOLASE Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BIOLASE's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BIOLASE could also be used in its relative valuation, which is a method of valuing BIOLASE by comparing valuation metrics of similar companies.BIOLASE is currently under evaluation in shares owned by institutions category among its peers.
BIOLASE Fundamentals
| Return On Equity | -5.05 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.44) % | |||
| Operating Margin | (0.45) % | |||
| Current Valuation | 13.65 M | |||
| Shares Outstanding | 33.4 M | |||
| Shares Owned By Insiders | 0.32 % | |||
| Shares Owned By Institutions | 8.97 % | |||
| Number Of Shares Shorted | 2.1 M | |||
| Price To Earning | (7.23) X | |||
| Price To Book | 0.77 X | |||
| Price To Sales | 0.1 X | |||
| Revenue | 49.16 M | |||
| Gross Profit | 16.53 M | |||
| EBITDA | (15.14 M) | |||
| Net Income | (20.63 M) | |||
| Cash And Equivalents | 9.96 M | |||
| Cash Per Share | 1.39 X | |||
| Total Debt | 17.91 M | |||
| Debt To Equity | 1.07 % | |||
| Current Ratio | 2.46 X | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (14.09 M) | |||
| Short Ratio | 1.09 X | |||
| Earnings Per Share | (11.97) X | |||
| Price To Earnings To Growth | (0.22) X | |||
| Target Price | 1.95 | |||
| Number Of Employees | 157 | |||
| Beta | 0.75 | |||
| Market Capitalization | 4.31 M | |||
| Total Asset | 35.1 M | |||
| Retained Earnings | (316.8 M) | |||
| Working Capital | 5.2 M | |||
| Current Asset | 34.8 M | |||
| Current Liabilities | 15.11 M | |||
| Net Asset | 35.1 M |
About BIOLASE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BIOLASE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BIOLASE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BIOLASE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in BIOLASE Stock
If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |